OVPSYCH2: A randomised study of psychological support versus standard of care following chemotherapy for ovarian cancer
Sarah P. Blagden(Churchill Hospital), L. Howells, Adrian Cook(University College London), Gianfilippo Bertelli, Rosalind Glasspool(Institut Bergonié), Chrissie Butcher(University of Oxford), Sir Edward Hughes, Michelle Ferguson(Ninewells Hospital), Sharon Love(Nuffield Orthopaedic Centre), René L. Roux(Churchill Hospital), María Cristina Quijano Martínez(Hammersmith Hospital), Shibani Nicum(London Cancer), C. Marriott, Melanie Mackean(Edinburgh Cancer Research), Eleni Frangou(Nuffield Orthopaedic Centre), Héctor G. Pálmer(CIBBIM-Nanomedicine), S. Black, Andrew A. James, Rosemary Lord(Clatterbridge Cancer Centre NHS Foundation Trust)
Cited by 1
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277
Performance status score: do patients and their oncologists agree?
|British Journal of Cancer|2003|222